Reduction of Advanced Liver Fibrosis by Short-Term Targeted Delivery of An Angiotensin Receptor Blocker to Hepatic Stellate Cells in Rats
Montserrat Moreno(Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas), Ramón Bataller(Consorci Institut D'Investigacions Biomediques August Pi I Sunyer), Paul van der Hoeven, Marike van Beuge(University of Groningen), Constantino Fondevila(Hospital Clínic de Barcelona), David A. Brenner(Institute of Medical Microbiology and Hygiene), Pau Sancho‐Bru(Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas), M. Lacombe(Université du Québec à Rimouski), Klaas Poelstra(University of Groningen), Vicente Arroyo(European Foundation for the Study of Chronic Liver Failure), Pere Ginès(Hospital Clínic de Barcelona), Leonie Beljaars(University of Groningen), Jai Prakash(Radboud University Nijmegen), Teresa Gonzalo(University of Groningen), Kai Temming(University of Groningen), Josine Swart(University of Groningen), Robbert J. Kok(Utrecht University)
Cited by 133
Related Papers
Liver fibrosis
|Journal of Clinical Investigation|2005|4.7k
A multisociety Delphi consensus statement on new fatty liver disease nomenclature
|Hepatology|2023|2.9k
EASL Clinical Practice Guidelines for the management of patients with decompensated cirrhosis
|Journal of Hepatology|2018|2.8k
A multisociety Delphi consensus statement on new fatty liver disease nomenclature
|Journal of Hepatology|2023|2.7k
Compensated cirrhosis: Natural history and prognostic factors
|Hepatology|1987|1.1k